Lee Sung bought CYTK
June 24, 2026 · Form 4 insider transaction
Lee Sung bought 9,307 shares of Cytokinetics, Incorporated at $44.36 per share, a transaction worth $412.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
9,307
Price
$44.36
Total value
$412.9K
InsiderLee Sung
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 24, 2026
Filing dateJune 29, 2026
Shares owned after95,898
OwnershipDirect
10b5-1 planNo
AmendedNo